Cleveland, Ohio; and Cairo, Egypt From Cleveland Clinic and Cairo University.
Plast Reconstr Surg. 2010 Oct;126(4):1300-1309. doi: 10.1097/PRS.0b013e3181ead057.
This work addresses the controversy regarding the indications and results of calcium phosphate cements in skull reconstruction through a meta-analysis of the published literature.
A PubMed search for articles reporting the use of calcium phosphate cements for skull reconstruction was performed. Data collected included age, volume of cement, defect size, material used, length of follow-up, placement in communication with paranasal sinuses or in irradiated fields, and complications.
Nineteen articles met the authors' inclusion criteria. The mean rates of complications were as follows: total complications, 13 percent (range, 0 to 62 percent); major complications, 9 percent (range, 0 to 62 percent); minor complications, 2 percent (range, 0 to 5 percent); infection, 5 percent (range, 0 to 22 percent); reoperation, 14 percent (range, 0 to 62 percent); and secondary surgery for contour correction, 1 percent (range, 0 to 12 percent). There was significant heterogeneity in the estimated rate of total and major complications, infection, and reoperation (p < 0.001), but minor complications and secondary contour correction had less heterogeneity (p = 0.58 and p = 0.78, respectively). Radiotherapy and communication with the paranasal sinuses significantly increased the complication rate (p < 0.05). Duration between surgery and complications averaged 17.5 months (range, 1 to 89 months).
When mean complication rate and complication range of calcium phosphate cements in our meta-analysis were compared with previous large cranioplasty studies using methylmethacrylate or autogenous bone, calcium phosphate fared no better, and sometimes fared worse, than these other modalities. Calcium phosphate, therefore, should only be used selectively, and prospective long-term studies are needed to further refine its role in skull reconstruction.
本研究通过对已发表文献的荟萃分析,解决了关于磷酸钙骨水泥在颅骨重建中的适应证和结果的争议。
对报道使用磷酸钙骨水泥进行颅骨重建的文章进行了 PubMed 检索。收集的数据包括年龄、骨水泥体积、缺损大小、使用的材料、随访时间、与副鼻窦相通或在放射野内的位置以及并发症。
19 篇文章符合作者的纳入标准。并发症的总发生率如下:总并发症为 13%(范围:0 至 62%);主要并发症为 9%(范围:0 至 62%);次要并发症为 2%(范围:0 至 5%);感染为 5%(范围:0 至 22%);再次手术为 14%(范围:0 至 62%);二次手术用于矫正轮廓的为 1%(范围:0 至 12%)。总并发症和主要并发症、感染和再次手术的估计发生率存在显著异质性(p < 0.001),但次要并发症和二次轮廓矫正的异质性较小(p = 0.58 和 p = 0.78)。放射治疗和与副鼻窦相通显著增加了并发症发生率(p < 0.05)。手术至并发症的平均时间为 17.5 个月(范围:1 至 89 个月)。
当我们的荟萃分析中磷酸钙骨水泥的平均并发症发生率和并发症范围与使用甲基丙烯酸甲酯或自体骨的先前大型颅骨修复研究进行比较时,磷酸钙骨水泥的表现并不优于这些其他方法,有时甚至更差。因此,磷酸钙骨水泥应选择性使用,需要进行前瞻性长期研究,以进一步细化其在颅骨重建中的作用。